These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 107039)

  • 1. Experimental torticollis in the marmoset produced by injection of 6-hydroxydopamine into the ascending nigrostriatal pathway.
    Sambrook MA; Crossman AR; Slater P
    Exp Neurol; 1979 Mar; 63(3):583-93. PubMed ID: 107039
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental torticollis in the monkey produced by unilateral 6-hydroxy-dopamine brain lesions.
    Crossman AR; Sambrook MA
    Brain Res; 1978 Jun; 149(2):498-502. PubMed ID: 96912
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of centrally acting drugs on experimental torticollis in monkeys.
    Battista AF; Goldstein M; Miyamoto T; Matsumoto Y
    Adv Neurol; 1976; 14():329-38. PubMed ID: 821320
    [No Abstract]   [Full Text] [Related]  

  • 4. Where is L-DOPA decarboxylated in the striatum after 6-hydroxydopamine nigrotomy?
    Duvoisin RC; Mytilineou C
    Brain Res; 1978 Aug; 152(2):369-73. PubMed ID: 567088
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of anti-Parkinson drugs on catalepsy induced by -methyl-p-tyrosine in rats pretreated with intraventricular 6-hydroxydopamine.
    Cashin CH; Sutton S
    Br J Pharmacol; 1973 Mar; 47(3):658P-659P. PubMed ID: 4738385
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of chronic L-dopa treatment on the recovery of motor function in 6-hydroxydopamine-lesioned rats receiving ventral mesencephalic grafts.
    Blunt S; Jenner P; Marsden CD
    Neuroscience; 1991; 40(2):453-64. PubMed ID: 1902916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons.
    Ungerstedt U; Ljungberg T; Steg G
    Adv Neurol; 1974; 5():421-6. PubMed ID: 4531217
    [No Abstract]   [Full Text] [Related]  

  • 8. Pirouetting pigs: A large non-primate animal model based on unilateral 6-hydroxydopamine lesioning of the nigrostriatal pathway.
    Christensen AB; Sørensen JCH; Ettrup KS; Orlowski D; Bjarkam CR
    Brain Res Bull; 2018 May; 139():167-173. PubMed ID: 29462643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic agonists in animal models of parkinsonism.
    Poirier LJ
    Adv Neurol; 1975; 9():327-35. PubMed ID: 807089
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of 6-OHDA injected into the locus coeruleus on apomorphine-induced aggression.
    Puciłowski O; Kozak W; Valzelli L
    Pharmacol Biochem Behav; 1986 Mar; 24(3):773-5. PubMed ID: 2422669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of DOPA and haloperidol on experimental torticollis originating in the mesencephalon and its modulation by stimulation of the caudate nucleus].
    Arushanian EB; Dutov AA
    Farmakol Toksikol; 1983; 46(2):24-8. PubMed ID: 6852215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in research on Parkinsonism.
    Rinne UK
    Acta Neurol Scand Suppl; 1978; 67():77-113. PubMed ID: 31053
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of (+)-amphetamine and apomorphine on visually determined behaviour in the marmoset [proceedings].
    Ridley RM
    Br J Pharmacol; 1978 Jun; 63(2):382P-383P. PubMed ID: 96900
    [No Abstract]   [Full Text] [Related]  

  • 14. [Quantitative evaluation of the cytoarchitectonic reorganization of the locus coeruleus in the brain stem under the influence of 6-hydroxydopamine].
    Usova IP; Kovbasa SI
    Biull Eksp Biol Med; 1988 Nov; 106(11):635-8. PubMed ID: 3143427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Costall B; Naylor RJ; Pycock C
    Eur J Pharmacol; 1976 Feb; 35(2):276-83. PubMed ID: 942921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural effects of chronic amphetamine and their reversal by haloperidol in the marmoset [proceedings].
    Baker HF; Ridley RM
    Br J Pharmacol; 1979 May; 66(1):146P-147P. PubMed ID: 110385
    [No Abstract]   [Full Text] [Related]  

  • 17. The behavioural effects of (+)-amphetamine and apomorphine in the marmoset [proceedings].
    Ridley RM; Crow TJ
    Br J Pharmacol; 1978 Mar; 62(3):393P. PubMed ID: 416868
    [No Abstract]   [Full Text] [Related]  

  • 18. Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra.
    Price MT; Fibiger HC
    Eur J Pharmacol; 1974 Dec; 29(2):249-52. PubMed ID: 4613562
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of L-dopa alone and with benserazide on the spontaneous activity of striatal neurones in normal and 6-hydroxydopamine-lesioned rats.
    Chang WY; Webster RA
    Br J Pharmacol; 1997 May; 121(2):331-7. PubMed ID: 9154345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An open study of a new formulation of the levodopa and benserazide combination in the treatment of fluctuations of motor performance in patients with Parkinson's disease].
    Pezzoli G; Tesei S; Cossutta E; Ferrante C; Zecchinelli A; Scarlato G
    Clin Ter; 1988 Apr; 125(2):115-20. PubMed ID: 2973932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.